Stada Hints At Further Deals To Come As It Posts Big Sales Rise
Germany's Stada posts 22% jump in first half sales thanks to recent deals and reveals that more acquisitions may soon follow.
You may also be interested in...
R&D partnerships are key to Stada's ambitious growth strategy, the company's new CHC innovation chief, Steve Makin tells HBW Insight, in the second part of an exclusive interview. CBD and probiotics are particularly exciting areas within the post-COVID wellness/prevention mega-trend, he says, in which Stada is already making headway with new products.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales in excess of €100m.
Stada has added to its consumer healthcare business in the Philippines by acquiring the Fern C range of vitamin C food supplements.